Categories Earnings, Health Care

Abbott Laboratories net earnings soar in first quarter

Abbott Laboratories (ABT) announced its first-quarter 2019 earnings results on Wednesday, April 17, before the opening bell.

In the three-month period, worldwide sales grew 2% to $7.5 billion, with earnings from continuing operations jumping 65% to 38 cents per diluted share. Adjusted diluted EPS from continuing operations improved by 6.3% to $0.63.

Total net earnings jumped 61% year-over-year to $672 million.

Abbott Laboratories Q1 earnings soar

Back in January, Abbott also received the FDA approval for a “new, expanded indication” for its MitraClip device to treat clinically significant secondary mitral regurgitation — a leaky heart valve resulting from advanced heart failure.

Then in March, Abbott obtained the CE Mark for its Alinity (molecular) diagnostics system and testing assays to aid in infectious disease testing.

“We’re right on track with our expectations to start the year,” said Abbott CEO Miles D. White, “…all of our key long-term growth drivers are performing well and we’re targeting another year of strong sales and earnings growth.”

Abbott now projects full-year 2019 GAAP earnings to be between $1.95 to $2.05 per diluted share, and adjusted diluted earnings from continuing operations to be $3.15-3.25 per share for the same period.

For the second quarter of 2019, Abbott sees GAAP diluted EPS of $0.47-0.49, and projects adjusted diluted earnings from continuing operations of $0.79-0.81 per share.

 

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

Does Unity Software (U) stock has more room to run?

Last month, the IPO market was in a full swing. IPOs of Snowflake (NYSE: SNOW) and JFROG (NASDAQ: FROG) had an impressive opening day in September, the former creating a

PepsiCo (PEP): Steady snacking habits amid pandemic drive strong quarter for beverage giant

PepsiCo Inc. (NASDAQ: PEP) beat market expectations on both revenue and earnings for the third quarter of 2020. The company saw the momentum continue in its snacks business while the

Does the virus-driven boom make Electronic Arts (EA) a good investment?

With more and more people turning to virtual entertainment sources, amid the virus-related movement restrictions, video game publishers like Electronic Arts (NASDAQ: EA) are witnessing unusually high demand. Not surprisingly,

Leave a Reply

Your email address will not be published. Required fields are marked *

Add Comment
Loading...

Cancel
Viewing Highlight
Loading...
Highlight
Close
Top